Evidence map›Paper›PMID 31552202›Full record

ArticleFrontiers in cellular and infection microbiology2019

Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles.

Uchini S Kosgodage, Paul Matewele, Brigitte Awamaria, Igor Kraev, Purva Warde, Giulia Mastroianni, Alistair V Nunn, Geoffrey W Guy, Jimmy D Bell, Jameel M Inal and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Efficacy of Cannabidiol in Reducing Virulence ofInternational journal of molecular sciences · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. In vitro antimicrobial activity of Thai stick cannabis Hang Kra Rog Phu Phan (Journal of advanced veterinary and animal research · 2025
    Article
  10. Article
  11. Cannabidiol (CBD) Acts as an Antioxidant onAntibiotics (Basel, Switzerland) · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Antimicrobial, Probiotic, and Immunomodulatory Potential ofAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Uchini S KosgodageCellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom.
Paul MateweleCellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom.
Brigitte AwamariaCellular and Molecular Immunology Research Centre, School of Human Sciences, London Metropolitan University, London, United Kingdom.
Igor KraevSchool of Life, Health and Chemical Sciences, The Open University, Milton Keynes, United Kingdom.
Purva WardeBioscience Research Group, Extracellular Vesicle Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Giulia MastroianniSchool of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom.
Alistair V NunnResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Geoffrey W GuyGW Pharmaceuticals Research, Cambridge, United Kingdom.
Jimmy D BellResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Jameel M InalBioscience Research Group, Extracellular Vesicle Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Sigrun LangeTissue Architecture and Regeneration Research Group, School of Life Sciences, University of Westminster, London, United Kingdom.
London Metropolitan University · GBUniversity of Westminster · GBUniversity of Hertfordshire · GBGW Pharmaceuticals (United Kingdom) · GBQueen Mary University of London · GBThe Open University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Membrane vesicles (MVs) released from bacteria participate in cell communication and host-pathogen interactions. Roles for MVs in antibiotic resistance are gaining increased attention and in this study we investigated if known anti-bacterial effects of cannabidiol (CBD), a phytocannabinoid from

Indexed as

Anti-Bacterial AgentsCannabidiolCell MembraneDrug SynergismEscherichia coliMicrobial ViabilitySecretory VesiclesStaphylococcus aureusAnti-Bacterial AgentsCannabidiolantibiotic resistancebacterial membrane vesicles (MVs)cannabidiol (CBD)E. coli VCS257gram-negativegram-positiveS. aureus subsp. aureus Rosenbach

Identifiers

PMID31552202
PMCPMC6747004
OpenAlexW2970129212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.